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ABSTRACT
The RNA-binding protein, HuR, is involved in the
stabilization of AU-rich element-containing mRNAs
with products that are involved in cell-cycle pro-
gression, cell differentiation and inflammation.
We show that there are multiple polyadenylation
variants of HuR mRNA that differ in their abundance,
using both bioinformatics and experimental
approaches. A polyadenylation variant with distal
poly(A) signal is a rare transcript that harbors func-
tional AU-rich elements (ARE) in the 3’UTR. A mini-
mal 60-nt region, but not a mutant form, fused to
reporter-3’UTR constructs was able to downregu-
late the reporter activity. The most predominant
and alternatively polyadenylated mature transcript
does not contain the ARE. HuR itself binds HuR
mRNA, and upregulated the activity of reporter
from constructs fused with ARE-isoform and the
HuR ARE. Wild-type tristetraprolin (TTP), but
not the zinc finger mutant TTP, competes for HuR
binding and upregulation of HuR mRNA. The study
shows that the HuR gene codes for several
polyadenylation variants differentially regulated
by AU-rich elements, and demonstrates an auto-
regulatory role of HuR.
INTRODUCTION
Transcriptional and post-transcriptional regulation
mechanisms ensure tight control of gene expression in
many physiological and cellular processes, for example,
during responses to external stimuli and stress. Post-
transcriptional regulation contributes signiﬁcantly to
the rapid and transient nature of these biological pro-
cesses, and comprises multiple steps including RNA pro-
cessing, export, localization, degradation and translation.
The RNA-binding proteins play key roles in each of
these processes. The stability of the mRNA, which is an
important regulatory step, can be modulated by inactiva-
tion of RNA decay-promoting proteins. Examples of
those are the zinc ﬁnger protein, tristetraprolin (TTP)
(1), K-homology splicing-regulatory protein (KSRP) (2),
butyrate response factor 1 (3) and certain gene products of
the AU-rich element (ARE)/poly(U)-binding/degradation
factor 1 (AUF1) (4). The mRNA stability can be enhanced
by the activity of mRNA stabilization-promoting proteins
such as human antigen R (HuR).
HuR is a member of the mammalian homologs of
embryonic lethal abnormal vision (ELAV) proteins com-
prising a group of RNA-binding proteins ﬁrst described
in Drosophila (5). The HuR gene is localized to human
chromosome 19p13.2 (6) and according to the GenBank
RefSeq database, the reference HuR transcript encodes a
6-kb mRNA derived from six exons, evidence of other
variants is presented in this paper. The HuR protein is
composed of 326 amino acids. It is predominantly nuclear,
but translocates to the cytoplasm upon cellular activation,
binds selected mRNAs and causes their stabilization (7).
HuR and other members of ELAV proteins possess
three RNA-recognition motifs through which they bind
with high aﬃnity to speciﬁc mRNAs bearing AU- and
U-rich sequences aﬀecting their stability and/or transla-
tion (8–12). HuR is implicated in the stabilization of
a number of ARE- and U-rich mRNAs such as those
involved in cancer and inﬂammation, for example,
COX-2, urokinase activator (uPA), certain chemokines
such as IL-8, Cyclins A, B, D and p21 (10,12–15).
Large-scale analysis involving proﬁling of mRNAs that
are bound to HuR protein, reveals that the repertoire of
HuR mRNA targets are not limited and contain many
previously unrecognized mRNAs (11,16,17).
Using the whole transcriptome bioinformatics
approach, we and others have previously found that
there are many genes that code for alternative polyadeny-
lation variants in which they exist as long 30 untranslated
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non-ARE isoforms (18,19). The AREs which largely
exist in the 30UTR comprise diﬀerent classes, ranging
from highly homogeneous overlapping repeats of AUU
UA to heterogeneous AU- and U-rich sequences (20).
They are among the most important mRNA decay deter-
minants and promote deadenylation of several ARE-
mRNAs both in vivo and in vitro (66) and also promote
decapping (67). Following deadenylation, the main degra-
dation pathway seems to involve 30 to 50 exonuclease activ-
ity (68). Thus, the presence of ARE alternative forms
allows diﬀerential regulation of mRNA decay.
The sequence-functional characteristics of the HuR
30UTR which harbors diﬀerent polyadenylation signals
and their role in alternative polyadenylation are not
known. This study provides evidence that the RNA bind-
ing protein, HuR, gene codes for several alternative
polyadenylation variants that results in their diﬀerential
expression patterns, ARE involvement, and response to
HuR itself. We found that the 6-kb alternative polyade-
nylation transcript is a rare transcript, and determined a
functional ARE mRNA decay element that is subject to
binding and auto-regulation by HuR. Moreover, we found
that TTP can compete for HuR binding to its own HuR
mRNA. Several cancers, including breast, colon, gastric,
prostate and ovarian cancers, have been linked to over-
expression of HuR and increased cytoplasmic localization,
when compared to normal tissues (21–25). Thus, under-
standing HuR regulatory pathways may lead to further
understanding of the role of HuR in disease, particularly
in cancer and inﬂammation.
MATERIALS AND METHODS
Cell lines and transfection
HEK293 and HeLa cell lines were obtained from
American Type Culture Collection (ATCC; Rockville,
MD, USA) and cultured in RPMI 1640 (Invitrogen,
Carlsbad, CA, USA) supplemented with 10% FBS and
antibiotics. Huh-7 cell line was obtained from Dr.
Stephen Polyak (University of Washington, Seattle, WA,
USA) and was propagated in DMEM medium with 10%
FBS and antibiotics. HEK 293 cells were transfected with
pcDNA3.1 vector, pcDNA3.1 containing full-length
human cDNA for HuR (kindly provided by Dr.
Christopher Moroni, Basel, Switzerland). The wild type
TTP and C124R mutant of CMV.hTTP.tag vectors were
obtained from Dr. Perry Blackshear (NIH) and subcloned
into pCR3.1 vector (pcDNA 3.1 equivalent vector for TA
overhang cloning). Transfections were performed in
medium without serum using Lipofectamine 2000
(Invitrogen) for 6h, followed by replacing the medium
with serum-supplemented medium. Transient transfec-
tions were continued for 18h.
RNA preparation and northern blot analysis
Total RNA was extracted using Tri Reagent (Molecular
Research Center, Cincinnati, OH, USA) and 15mg of each
sample was separated by electrophoresis through a 1.2%
agarose/2.2M formaldehyde gel. Northern blotting was
performed with cDNA probes speciﬁc for HuR or
b-actin mRNA. The probes were labeled with
[a-32P]dCTP (Amersham) using a nick translation kit
(Invitrogen) and used for the standard northern blotting
technique, also previously described (26). RNA signals
were measured with a densitometer (Bio-Rad) and
Image analysis software (Amersham).
In later experiments, we switched to non-radioactive
labeling for the northern blotting. The EGFP sequence
was ampliﬁed using speciﬁc primers to EGFP in which
the reverse primer has T7 promoter sequence. The
sequence for the PCR primers are: forward 50 CTACTC
AGACAATGCGA TGCA 30 and the Reverse primer is 50
CCGAATTAACCCTCACTAAAGGG AGAGCGCAA
GAAATGG CTAG 30. The PCR product was used to
generate the DIG-labeled single-stranded antisense RNA
probe by in vitro transcription using T7 RNA polymerase
(Roche diagnostics, Germany). The DIG label is detected
by anti-DIG-AP conjugate with chemiluminescent sub-
strate CSPD (Roche) on northern membranes as recom-
mended by the manufacturer.
EST clustering
Clustering of ESTs found in ELAVL1 Unigene record,
Hs.184492, was performed using SEQMAN II
(DNASTAR, Inc., Madison, WI, USA). Initially, the
ESTs were pre-processed to remove sequences less than
100 bases, vector sequences (word size=10bp, at least
90% identity), and to trim low-quality ends by removing
ends based on a minimum number of two ambiguous resi-
dues (Ns) within a sliding window of 50 bases. Fragment
assembly in SEQMANII was used to cluster the ESTs
using the following parameters (match size of 50 consec-
utive bases bp and at least 90% identity), maximum added
gap per kilobase cluster is 50bp, maximum register is
30bp, gap penalty is 0.5 and gap length penalty is 1.0).
No chimeras’ contigs were observed. Consensus calling of
the clusters was with 75% as the minimum percentage of
identical residues at each position required to identify the
consensus base at this position using Trapezoidal Weights.
3’UTR PCR, construction and cloning of reporter plasmids
Regions that contain putative ARE and ARE-like
sequences which correspond to the partial 30UTRs of
HuR [NM_00419; 1146–2359nt for the 2.7-kb mature
transcript and 1146–2920nt for ARE-containing 6-kb
transcript and urokinase activator (NM_002658; 2161–
2301nt)] were obtained by RT-PCR. Brieﬂy, total RNA
was extracted by Tri Reagent from LPS-induced THP-1
cell line. The cDNAs were ampliﬁed by PCR in which the
forward primer contains BamHI site (underlined) and the
reverse primer with XbaI site (underlined) as follows: The
HuR 30UTR mature mRNA region (2.7-kb mRNA) was
ampliﬁed by: forward primer: 50 CAGCAGGGATCC TA
ACTCGCTCATGCTTTTTTTTG 30. Reverse primer: 50
CGACCTCTAGAATTCGAGCAAA ACAAAATC 30.
The HuR 30UTR of 6-kb transcript was ampliﬁed using
the following primers: Forward primer: 50 CAGCAGGG
ATCCTAACTCGCTCATGCTTTTTTTTG 30 and the
reverse primer: 50 CGACCTCTAGACACAGCCCC
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reverse primers are as follows: CAGCAGGGATCCCAC
TGTCTCAGTTTCACTTT 30 and 50 CGACCTCTAGA
CATCAGAAAAATCACATTTTATTG 30. The IL-8
30UTR forward and reverse primers are as follows: 50 G
CACCGGATCCGATGTTGTGAGGACATGTG 30 and
the reverse primer with XbaI site (underlined): 50 GCCAG
TCTAGAACCCTGATTGAAATTTAT 30. The PCR
products were puriﬁed, precipitated, and cut by BamHI
and XbaI sequentially, and subsequently ligated into
EGFP plasmid (Gene Therapy Systems, Inc., San Diego,
CA, USA) which is under CMV/Intron A constitutive
promoter. The 60-nt ARE spanning region of HuR and
uPA and their mutant forms were cloned in the expression
vectors as duplex with BamHI and XbaI overhangs. The
COX-2 30UTR 130-nt region (NM_000963; 1954–2083)
was made as duplex oligonucleotide. These short double-
stranded DNA were made by annealing two synthetic
complementary oligonucleotides. After ligation and trans-
formation, DNA from recombinant colonies was veriﬁed
by PCR using a forward vector speciﬁc primer and 30UTR
or ARE reverse primer.
Reporter transfection and activity assessment
Reporter constructs containing GFP-30UTR/ARE were
used in transient transfection at 25ng per 2 10
4cell/
well in 96-well microplates. Transfection was performed
with Lipofectamine 2000. In co-transfection experiments
the expression plasmids of HuR or TTP and mock
(pcDNA 3.1/pCR3.1) were kept constant as indicated.
Transfection eﬃciency and normalization to control was
achieved using GFP reporter fused with stable BGH
30UTR. The intra-well variance of any replicate groups
in ﬂuorescence is generally <6%, which does not warrant
intra-well normalization of transfection (27). Fluorescence
was quantitated using a sensitive bottom read instrument
ZENYTH 3100 (Anthos Labtec, Eugendorf, Austria).
Data are presented as mean value SEM of ﬂuorescence
intensity. For comparison between two groups (columns
on ﬁgures) the student paired t-test was used. Two-tailed
probabilities were reported. ANOVA was used to compar-
ison with more than two groups of data. Densitometry,
band detection, background subtraction and normaliza-
tion of images were performed using ImageMaster
Software (Amersham).
Real-time RT-PCR, and half-life determinations
For real-time measurements of half-lives of EGFP repor-
ters generated from constructs with HuR 30UTRs, primers
and TaqMan probe speciﬁc to EGFP were custom synthe-
sized by PE Applied Biosystems. The primers span the
CMV promoter intron A to control DNA contamination.
The 6-carboxyﬂuorescein (6FAM)-labeled TaqMan probe
that target CMV exon 1-EGFP (exon 2) junction sequence
was used. The probe design allowed further control
of DNA contamination. The control RPL0 mRNA
probe is labeled with a 50 reporter VIC dye (Applied
Biosystems). Cell-culture experiments for the mRNA
half-life determination were incubated with increasing
duration of actinomycin D treatment (5mg/ml) followed
by total RNA extraction and cDNA synthesis.
The real-time PCR was run on Chroma 4 thermocycler
instrument (BioRad). Standard curves for each gene
were generated to determine the relative concentrations
of ampliﬁed transcripts. The concentration of each tran-
script was then normalized to RPL0 mRNA levels and the
normalized values were used to calculate the half-lives.
Immunoprecipitation of HuR mRNA species
Pre-swollen protein A/G–Sepharose beads (Santa Cruz)
were pre-coated with 30ug of goat IgG (Santa Cruz),
mouse IgG (Santa Cruz), anti-HuR (Santa Cruz) or
anti-RNase L monoclonal antibody (Novus Biologics)
in NT2 buﬀer [50mM Tris–HCl (pH 7.4), 150mM
NaCl, 1mM MgCl2 and 0.05% NP-40]. The beads were
washed with NT2 buﬀer and incubated (2h, 48C) with cell
lysates in 1ml of NT2 buﬀer supplemented with DTT and
RNAseOut (Invitrogen). The beads were washed and
further treated with 100ml NT2 buﬀer that contains
10U RNase-free DNase I to remove genomic DNA con-
tamination, if any, for 15min at 308C, washed with NT2
buﬀer and further incubated in 100ml NT2 buﬀer contain-
ing 0.1% SDS and 0.5mg/ml proteinase K (558C, 20min).
RNA was isolated and used for semi-quantitative
RT-PCR. For real-time quantitative RT-PCR for HuR
mRNA, primer pair/TaqMan probes (Applied Biosysems)
were used in the same manner as above.
Semi-quantitative RT-PCR
RT reaction was performed using 200ng total RNA,
500ng oligo dT(18–23), 500mM dNTP mixture, 20U
RNAsin (Pharmacia), 200U of SuperScript II
(Invitrogen). Hot start PCR ampliﬁcation was performed
using Taq DNA polymerase (Qiagen). cDNA was ampli-
ﬁed according to an ampliﬁcation curve, for example,
b-actin mRNA and HuR mRNA were ampliﬁed at 28
cycles and 36 cycles, respectively. The ampliﬁcation
curve was determined for each cDNA of interest by plot-
ting increasing cycle numbers against ethidium bromide
stained gel intensity of the ampliﬁed products. The opti-
mum cycle number chosen is within the exponential phase
of the curve. Cycling was 948C for 60s, 608C for 60s and
728C for 60s using primers speciﬁc to, GFP, b-actin, HuR
intron, HuR exon or the last portion of terminal exon 6
(6-kb transcript). The GFP forward primer is 50 GAAGC
GTTCAACTAGCAGACC A30 and GFP reverse primer
is 50 CCATGCCATGTGTAATCCCAG 30. The b-actin
forward primer is 50 ATCTGGC ACCACACCTTCTAC
AATGAGCTGCG 30; b-actin reverse primer: 50 CGTCA
TACTCCTGCT TGCTGATCCACA 30. The b-actin pri-
mers were designed to span short intronic sequences so
that the larger PCR products would be shown in case
there was genomic DNA contamination. The sequence
of HuR exon 3/4 speciﬁc primers are as follows: forward
primer, 50 AACACGCTGAACGGCTTGAGGCT 30 and
reverse primer, CCGCCCAAACCGAGAGA ACAT 30.
The PCR using the exon 3/4 primers allows the spe-
ciﬁc ampliﬁcation of short PCR products (158 bases)
representing the HuR mRNA transcript but not the
pre-mRNA, since the latter would give 7.4kb that is not
3614 Nucleic Acids Research, 2009, Vol. 37,No. 11ampliﬁed with the PCR conditions that use an extension
time of 60s. In other words, the PCR is not a long-
distance PCR. The forward primer for HuR intron
(intron 3) is: 50 CAGCGGCAGGTGACTTGAGGAA
and the reverse primer is: 50 GCCCACGAACCCAGGA
GCCAGAA 30. The intron speciﬁc primers allow monitor-
ing of DNA contamination in absence of RT. The PCR
for the distal portion of exon 6, which exists also in the
6-kb transcript variant, utilized the following primers: The
forward primer is: 50 CCC AGAGCAGGTCAGCGTCT
C and the reverse primer is: 50 GGTGCTACAAGCCCG
TCATCA 30. In all of the above, PCR conditions allowed
at least semi-quantitative comparisons of signal strength
on agarose gels as the cycle number was chosen in the
exponential range which has not reached the plateau.
These comparisons were validated by generating PCR
products using diﬀerent cycles in which the signal strength
was within linearity up to 32 cycles for both GFP and
b-actin control and up to 38 cycles for HuR mRNA
following IP-RNA.
RNA EMSA, supershift and in vitro HuR translation
The sense RNA oligonucleotides corresponding to HuR
ARE and mutant ARE (Figure 3D) were custom synthe-
sized (Metabion) which were 50end-labeled with biotin and
HPLC puriﬁed. Unlabeled competitor oligonucleotides
were also synthesized. Ten femtomoles of the biotin-
labeled sense probe was incubated with 5mg of total cell
lysate for 30min at room temperature in 20ml of binding
buﬀer containing 10mM Tris–HCl (pH 7.5), 50mM KCl,
1mM DTT, 1mg of tRNA. Five microliters of 5  loading
buﬀer was added to the mixtures. Following nondenatur-
ing polyacrylamide gel electrophoresis, gel was transferred
onto positively charged nylon membrane (Amersham), and
UV-cross linked. The membrane was then subjected to
detection by chemiluminescent EMSA kit (Pierce) follow-
ing the manufacturer’s protocol. Competition assays were
performed in the same manner, except that 1000-fold
excess (10pmol) of mutant or unlabeled competitor ARE
RNA were pre-incubated with protein extract for 30min at
room temperature before the addition of the 50-biotiny-
lated probe. The RNA EMSA was also veriﬁed by recom-
binant HuR. Brieﬂy, HuR cDNA clone was transcribed
and translated using T7 RNA polymerase and the TNT-
coupled reticulocyte lysate system (Promega, USA)
according to the manufacturer’s protocol. Reaction com-
ponents included (0.5mg) human HuR cDNA plasmid and
24ml TNT reticulocyte T7 master mix in a ﬁnal volume of
25ml.Thereactionmixwasincubatedat308Cfor1.5h.The
supershift assay was carried in the same manner, except
that 2mg of anti-HuR antibody (sc-5483) (Santa cruz)
was pre-incubated with HEK293 protein extract for
30min before the addition of the labeled probe.
RESULTS
Bioinformatics evaluation of alternative polyadenylation
of HuR mRNA
The HuR gene structure and the polyadenylation var-
iants are depicted in Figure 1A. The HuR gene is
composed of ﬁve introns and six exons. The coding
region is in exons three, four and ﬁve, and part of
exon 6 (324nt of the total 5234-nt 30UTR), while the
majority of exon 6 is comprised of long 30UTR
(42163–47073). The detailed sequence information is
found in Supplementary Figure 1. According to the
EST data (below) and NCBI assembly, there are no
alternative spliced transcripts derived from the HuR
gene. However, the presence of multiple putative
poly(A) signals in the 30UTR, which is encoded in exon
6 (Figure 1A), suggests the presence of alternative poly-
adenylation variants. Thus, we have carried both bioin-
formatics and experimental analysis to investigate HuR
alternative polyadenylation.
We ﬁrst evaluated the HuR mRNA species by bioin-
formatics. Using a reﬁned EST clustering approach (18),
we clustered 460 ESTs. This resulted in a predominant
transcript of 2711 bases (68% of all the ESTs; Figure 1B)
and a smaller transcript of 1463 bases of lesser abun-
dance (23% of all ESTs). Both match the size of the
mRNA species in northern blot from HeLa cell line
(Figure 1C). Both of the transcripts (2.7- and 1.5-kb
variants) have ATTAAA as proximal poly(A) signal
and, as middle poly(A) signals in the 2.7-kb variant
(Supplementary Figure 1), these signals terminate at the
30ends within the last 20nt of the poly(A) site
(Figure 1B). Thus, the two mRNAs are likely alternative
polyadenylation variants. There was no EST cluster for
the reported 6-kb RefSeq mRNA that may represent the
longest and rare polyadenylation variant. The lack of an
EST contig consensus for the 6-kb mRNA is likely due
to the nonmerging of the long 6-kb mRNA 30UTR with
the 50ends of the EST. Thus, we examined the individual
EST that shows the presence of exon six terminal
sequence to be only 4.3% of the 30EST records (163
records; Supplementary Table 1) in which the distal
poly(A) signal, AATAAA is within the last 20nt. The
rare long ARE-positive 6kb can only be seen in northern
blot only after using a radioactively labeled cDNA probe
against HuR mRNA with extended exposure (Figure 1C,
lower panel). Furthermore, a weakly expressed 6-kb tran-
script in brain tissues was previously documented in
northern blots by another group (7).
Experimental evidence of HuR mRNA alternative
polyadenylation variants
The polyadenylation variants were further validated by
expressing enhanced green ﬂuorescence protein (EGFP)
coding region fused with 1.77-kb 30UTR of HuR that
contains the two putative poly(A) signals, i.e. the proximal
and the middle poly(A) signals (Figure 2A). The EGFP-
HuR 30UTR construct produced two alternative polyade-
nylation variants that corresponded to the expected sizes
of the bioinformatics-derived transcripts and northern
blotting (Figure 2B). Furthermore, the variants also cor-
responded to similar abundance levels as determined
by bioinformatics and viewed in the northern blots
(Figure 1). The most predominant band is the EGFP
mRNA with the middle poly(A) signal (2.1kb of GFP
Nucleic Acids Research, 2009,Vol.37, No. 11 3615mRNA), which corresponds to the natural HuR alterna-
tive transcript of 2.7kb.
RT-PCR experiments with primers speciﬁc to the 6-kb
form (distal part of exon 6) showed the presence of the
6-kb form in addition to other mRNAs (exons 3 and 4) in
three diﬀerent cell lines (Figure 2C). RT-PCR using exons
3 and 4 primers do not amplify genomic DNA because the
PCR conditions do not favor the long genomic region of
>7.2kb. In accordance with the northern blotting, the
semi-quantitative RT-PCR experiments with two diﬀerent
cycle numbers within exponential phase indicate that
the 6-kb mRNA levels are lower than those of all
HuR mRNA variants (Figure 2C). Based on all of
above bioinformatics and experimental analyses, it is con-
cluded that the mature mRNA of 2.7kb is the most pre-
dominant transcript which is also the most abundant
alternative polyadenylation variant and 6-kb transcript is
the rarest variant.
Analysis, cloning and functional validation of HuR
3’UTR AU-rich elements
Analysis of 30UTR (exon 6) of the HuR mRNA tran-
scripts indicated that the mature predominant mRNA
(2.7kb), which represents the middle polyadenylation var-
iant, lacks typical ARE that act as mRNA decay determi-
nants, although they have potential U-rich stretches
(dotted lines, Figure 3A). There is a typical ARE stretch
(Figure 3A; Supplementary Figure 1) that exists in the rare
6-kb transcript variant, which has distal poly(A) signal;
this ARE may be responsible for the rare presence of
the transcript. The ARE is a typical class 2 ARE or cluster
II (28) having four overlapping pentamers with only one
mismatch. Accordingly, we carried out experiments that
aim to understand the role of HuR 30UTR and these
AREs in HuR regulation.
We have cloned two 30UTR sequence regions, one
sequence region (1213nt) contains the proximal and
Figure 1. Bioinformatics and mRNA species assessment of HuR gene. (A) A gene structure for HuR (ELAVL1). Exons are denoted by the
green boxes while the red box denotes the terminal exon that harbors the entire 30UTR of HuR and their polyadenylation variant signals.
Positions for the speciﬁc primers used in this study are shown: for the pre-mRNA (intron; blue arrows), terminal sequences in exon 6 (6-kb
transcript, black arrows) and exon 3/4 (green arrows). Positions of putative pA signals leading to alternative polyadenylation are shown (vertical
arrows). pA denotes polyadenylation signal. (B) EST clustering strategy view of the ESTs belonging to the HuR. The top cluster represents  70% of
the 460 ESTs from Unigene Cluster (Hs.184492). The dark inner lines represent individual ESTs in the EST assembly. The bottom cluster represents
23% of the total ESTs in the assembly (individual ESTs are not shown). (C) Total RNA was extracted from HeLa cells and used for northern
blotting with cDNA probes to HuR and b-actin mRNA. Arrows show the two diﬀerent mRNA species as assessed by size markers. Lower panel
showed the three mRNA variants with over-exposed autoradiography.
3616 Nucleic Acids Research, 2009, Vol. 37,No. 11middle poly(A) signals and does not harbor the ARE, and
thus represents the most abundant 2.7-kb transcript var-
iant. The second region (1774nt) includes further down-
stream sequences that contain the typical ARE stretch
which only exists in the 6-kb transcript (Figure 3A and
Supplementary Figure 1). We fused the 30UTR to an
EGFP coding region as a reporter expression system.
This system in our hands is sensitive, with minimal
(mostly, <6%) variation in transfection eﬃciency, has a
large dynamic linear range (27); and can be performed on
live cells. Several known ARE-bearing 30UTRs were also
used in these experiments. The ARE-bearing 30UTR
sequences of the 6-kb transcript, but not that of the con-
trol EEFA1A 30UTR or the short HuR 30UTR of the
2.7-kb transcript that lacks the ARE, led to reduction of
GFP reporter (70% reduction) from the fused constructs
(Figure 3B). Likewise, the ARE-bearing 30UTR of known
mRNAs (uPA, COX-2 and IL-8) led to signiﬁcant reduc-
tion (60–70%) of the reporter activity (Figure 3B). The
EEFA1A 30UTR sequence used (210nt) acts as a control
for the uPA, COX-2 and IL-8 30UTR regions that were
cloned; all are within close size range of 130–220 bases.
We considered the HuR non-ARE 30UTR (1.2kb) as a
control for the ARE-bearing transcript HuR 30UTR
(1.7kb) for two reasons; ﬁrst, housekeeping stable
30UTRs tend to be of smaller sizes, average length of
650 30 (27,29,30), and thus cannot be used as control
for long 30UTRs; and second, the reporter activity
expressed from 1.2-kb non-ARE HuR 30UTR construct
did not change from the EEFA1A control (Figure 3B).
The 30UTR sequence of the 6-kb transcript that con-
tains the ARE strongly destabilized the reporter mRNA;
there was 80% reduction in the mRNA levels when com-
pared to the control activity (Figure 3C). In contrast, the
30UTR of the 2.7-kb transcript (Figure 3C) did not lead to
an appreciable or statistically signiﬁcant reduction either
in the reporter activity or in mRNA levels. Thus, class
2 ARE-containing 30UTR of the 6-kb transcript, but not
the 30UTR of the 2.7-kb abundant transcript, was func-
tional in regard to the mRNA destabilization activity.
As a control, the uPA 30UTR caused signiﬁcant reduction
of the reporter mRNA levels.
In order to conﬁrm the genuine involvement of the
AREs themselves, rather than the 30UTR as a large
region in the 6-kb transcript, we fused the reporter with
a 60-nt region that spans the putative ARE in the 6-kb
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Figure 2. Experimental validation of the HuR polyadenylation variants. (A) Cloning of 1774nt of 30UTR of HuR mRNA that contains the putative
two poly(A) signals into EGFP expression vector that is under the control of CMV IE promoter and stable bovine growth hormone 30UTR/poly(A)
signal. (B) HEK393 cells were transfected with the EGFP construct in (A) using Lipofectamine 2000 for 16h. Northern blotting was performed using
antisense probe to EGFP. Numbers denote the expected length of the polyadenylation variants of EGFP-HuR 30UTR mRNAs (lanes 2 and 3) and
EGFP-BGH 30UTR transcripts (lane 1)—denote positions for the 18S ( 2kb) and 28S rRNA ( 5kb) bands. (C) DNase-treated total RNA extracted
from three diﬀerent cell lines (1, HeLa; 2, HEK293; and 3, Huh7) were used. RT-PCRs were performed for HuR gene products encoding the 6-kb
transcript (distal polyadenylation variant; black-colored arrows in Figure 1A) and exon 3/4 containing forms (all polyadenylation variants, green-
colored arrows in Figure 1A) using speciﬁc primers as outlined above.  These primers do not amplify intervening introns between exons 3 and 4
(7.2kb) since RT-PCR conditions were performed with short extension times. RT-PCR control without RT to monitor genomic contamination was
used with intron-speciﬁc primers.
Nucleic Acids Research, 2009,Vol.37, No. 11 3617transcript (Supplementary Figure 1), and also with the
same sequence but with discrete mutation of the penta-
mers (Figure 3D, insert table). Many functional ARE
regions that respond to both destabilization and stabiliza-
tion signals, particularly those of class 2 ARE, were shown
within the length of 60nt (31). The AREs were able to
cause signiﬁcant reduction in the reporter activity, down
to 20% of the control 30UTR that has 60nt of human
growth hormone GH1 non-ARE sequence (Figure 3D).
As a control, the mutant ARE of the same 60-nt length
inserted in the wild-type 30UTR was not able to trigger
reduction in the reporter activity (Figure 3D). As a posi-
tive ARE control, a 60-nt region of uPA, 30UTR caused
signiﬁcant reduction in the reporter activity.
HuR regulation of HuR 3’UTR and ARE
We next investigated the eﬀect of transient transfection of
HuR-c-myc-his cDNA expression vector into HEK293
cells on the EGFP reporter expression from the reporter
constructs fused with the diﬀerent HuR 30UTR and other
control 30UTR sequences (Figure 4A). Western blotting
conﬁrmed the expression of the transfected c-myc-his
Figure 3. Diﬀerential Involvement of AU-rich elements in HuR polyadenylation variants. (A) Schematic diagram of exon 6 of HuR that contains
ARE and reporter constructs. Sequences from the EEF1A1 30UTR (Control, construct 1), 2.7kb mRNA 30UTR (construct 2), 6-kb transcript 30UTR
(construct 3), uPA 30UTR (construct 4), COX-2 30UTR (construct 5) and IL-8 30UTR (construct 6) were inserted in BamHI/XbaI sites as described
in ‘Materials and Methods’ section. (B) Analysis of GFP reporter activity generated from GFP mRNA fused with the indicated 30UTR. HEK293
cells were transfected with the diﬀerent 30UTR constructs in 96-well microplates. Reporter activity was assessed in 96-well black clear-bottom plates
by measuring bottom ﬂuorescence using bottom-read ﬂuorometer. The EEF1A1 30UTR is the control construct in which its ﬂuorescence activity was
taken as 100% and data are presented as mean SEM (n=4) of % of the control.    Denote P-values of <0.01 and <0.005, respectively (Student’s
t-test). Percent transfection eﬃciency in the control was 80% with a coeﬃcient of variation of <6%, thus, normalization with another vector was not
needed (27). (C) Analysis of GFP mRNA levels by quantitative real-time RT-PCR. HEK293 cells were transfected with the diﬀerent 30UTR
constructs in 6-well plates. Total RNA was extracted and real-time quantitative RT-PCR was performed using primers and Taqman probe speciﬁc
to GFP reporter sequence as described in ‘Materials and methods’ section. The ﬂuorescence activity from control (EEF1A1) 30UTR-fused construct
was taken as 100%. Data (mean SEM) was presented as percentage of control. (D) A 60-nt double-stranded oligonucleotide corresponding to the
ARE regions from HuR 6-kb 30UTR, uPA 30UTR and control stable growth hormone (GH1) 30UTR were fused with EGFP reporter construct.
Furthermore, 60-nt double-stranded oligonucleotides as mutant forms of the HuR ARE and uPA were fused with GFP reporter construct (sequences
of ARE and their mutants are shown). These constructs were used for HEK293 transfection. Percentage of control 30UTR (EEF1A1)-linked
construct ﬂuorescence activity (100%) are presented as mean SEM (n=4).    Denote P-values of <0.005 (Student t-test).
3618 Nucleic Acids Research, 2009, Vol. 37,No. 11HuR cDNA, which has larger weight compared to the
endogenous HuR (Figure 4B). We found that HuR
over-expression can preferentially increase the activity of
the reporter gene fused with the ARE-bearing 6-kb tran-
script 30UTR sequence (2.3-fold; P<0.01), compared to
the activity of reporter fused with abundant 2.7-kb
transcript 30UTR (1.4-fold) or control EEFA1A 30UTR
sequence (Figure 4A). The uPA (13), COX-2 and IL-8
30UTR, as positive controls were also responsive to HuR
in a similar degree (Figure 4A). To determine if the
minimal 60-nt region was responsible for HuR-induced
upregulation of the reporter activity, we used the reporter
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Figure 4. Eﬀect of HuR over-expression on HuR 30UTR and HuR ARE. (A) HEK293 cells in 96-well plates were co-transfected with 37ng pcDNA
3.1 empty vector or HuR-c-myc-his expressing pcDNA 3.1 vector and 25ng of each of EGFP-30UTR reporter vectors as shown. The reporter 30UTR
constructs were described in Figure 3A. Data mean SEM of quadruplicates presented as % of reporter ﬂuorescence with control EEF1A1 30UTR
taken as 100%. Percent transfection eﬃciency in the control was 80% with a coeﬃcient of variation of <6%, thus, normalization with another vector
was not needed (27). (B) Representative western blotting conﬁrming expression of the transfected c-myc-his-HuR cDNA is shown. Inset is a longer
gel run for larger separation of endogenous and transfected HuR. (C) HEK293 cells in 96-well plates were co-transfected with reporter vectors and
either pcDNA3.1 (control) or HuR expression pcDNA3.1. The reporter vector is EGFP fused with 30UTR that contains a 60nt corresponding to the
ARE regions from HuR the 6-kb variant 30UTR, uPA 30UTR, control GH1 sequence, a 60nt as mutant form of the HuR 6-kb ARE (Figure 3D,
inset table) and another 60nt representing U-rich control that lacks HuR binding site (17). Fluorescence data of mean SEM of quadruplicates were
obtained. The ﬂuorescence levels obtained from cells transfected with the pcDNA3.1 and the reporter with control GH1 30UTR were taken as 100%.
The y-axis numbers represent percentages of this control.    Denotes P-values of <0.001 (Student t-test) when compared to control. (D) HEK293
cells were transfected with the EEF1A1 30UTR (Control), 2.7-kb mRNA 30UTR, 6-kb transcript 30UTR (constructs 1–3, Figure 3A) overnight and
then treated with AcD (5mg/ml). Total RNA was extracted at the indicated time points and subjected to RT-PCR using primer pair/TaqMan probe
speciﬁc to EGFP mRNA. The TaqMan primer/probe spans an intron–exon-junction sequence for eﬃcient control of DNA contamination. Half-life
mRNA determinations were obtained by plotting the changes in RPL0-normalized EGFP mRNA levels expressed as a percentage of that seen at
time 0 (taken as 100%; y-axis) against AcD treatment duration (x-axis). RPL0 is a housekeeping gene. Data are from one representative experiment
of at least two independent experiments. Details are given in ‘Materials and Methods’ section.
Nucleic Acids Research, 2009,Vol.37, No. 11 3619constructs in which the 30UTR contains only the 60-nt
ARE region. Over-expression of HuR caused a speciﬁc
increase (1.9-fold, P<0.001) in the activity of the reporter
fused with HuR 60-nt ARE derived from the 6-kb poly(A)
variant transcript, but not with the mutant sequence
(Figure 4C). In addition, as a positive control, HuR
caused increase of the reporter activity from the construct
fused with uPA 60nt but not the mutant sequence
(Figure 4C). Use of a U-rich 60-nt control, randomly
selected from a library of U-rich sequences (our unpub-
lished data) that lacks an HuR recognition site (17), was
unresponsive to HuR (Figure 4C). As a negative control,
GH1 60-nt sequence was not responsive to HuR over-
expression.
Further, we performed half-life experiments using
real-time RT PCR to measure the eﬀects of HuR over-
expression. The half-life of the reporter mRNA was sim-
ilar in case of the control EEFA1A 30UTR in the presence
or absence of HuR over-expression ( 4h), whereas, the
half-life of the reporter mRNA released from the 6-kb
HuR mRNA sequence (2.5h) increased and become
stabilized due to HuR over-expression (>8h;
Figure 4D). The half-life of the short HuR mRNA tran-
script sequence did not signiﬁcantly change due to HuR
over-expression (Figure 4D).
HuR binding to HuR mRNA
Since HuR is known to bind and stabilize ARE-mRNAs,
including their pre-mRNA forms, we examined the bind-
ing of HuR to HuR mRNA and the ARE-containing
polyadenylation 6-kb transcript. An immunoprecipitation
(IP) assay was performed under conditions that preserved
endogenous ribonuclear protein associations (11). An RT-
PCR of the IP RNA material obtained after anti-HuR
or IgG control was performed using primers speciﬁc for
exon 3/4. The exon 3/4 amplicon (green-colored arrows in
Figure 1A,) represents all transcripts of HuR mRNA.
HuR interacted with at least one isoform of the HuR
mRNA (Figure 5A, top panel). To pinpoint speciﬁcally
whether the 6kb or the pre-mRNA was bound to HuR,
we performed RT-PCRs of the IP RNA material obtained
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Figure 5. Binding of HuR protein to HuR mRNA and consequences of HuR over-expression. (A) The binding of endogenous HuR to endogenous
target mRNA was detected by RT-PCR of RNA material obtained by precipitation with either anti-HuR antibody or goat IgG control antibody.
Primers speciﬁc to the intron (pre-mRNA), distal part of exon 6 (6-kb transcript) or all mRNA (exons 3 and 4) were used in the RT-PCR reaction
with a cycle number that allows at least semi-quantitative comparison as indicated in ‘Materials and Methods’ section. The positions and types/size
of PCR products are shown in Figures 1A and 2C. All RNA samples were treated with DNase to eliminate genomic DNA contamination. In
addition, RT-PCR (intron) was performed without RT to further monitor DNA contamination (lower panel). This protocol is performed according
to a standard protocol (11,58,59). (B) Real-time RT-PCR monitoring of HuR mRNA levels following precipitation of endogenous HuR with either
anti-HuR antibody or goat IgG control as described above. The real-time RT-PCR was performed with primers/TaqMan probe speciﬁc to HuR
mRNA and RPL0 (background control); the TaqMan primer pair and probe span intron and exon–intron junction, respectively, in HuR mRNA to
eliminate signal quantitation due to DNA contamination. Lower panel shows data in terms of % speciﬁc binding (anti-HuR/IgG). The data are one
representative experiments of two with mean SEM of triplicates. (C) RNA-binding activity of endogenous and exogenous HuR. The HuR ARE 60-
nt probe (lane 1) was incubated with 5mg HEK293 protein lysate (lanes 2–4). Competition assay was carried in the presence (+) of 1000-fold excess
of unlabeled RNA competitor (lane 3). In vitro translated HuR protein was incubated with either the HuR ARE (lane 5) or the mutant ARE (lane 6)
oligonucleotide. Arrows indicate RNA–protein complexes formation in the presence of protein lysate. The supershift assay was carried out in the
same manner, except that protein lysate was pre-incubated with anti-HuR antibody for 30min at room temperature before the addition of
biotinylated probe. Asterisk Indicates the super-shifted position.
3620 Nucleic Acids Research, 2009, Vol. 37,No. 11after anti-HuR or IgG control, using primers speciﬁc to
the 6-kb transcript or HuR pre-mRNA (intron). We found
that HuR interacted with the 6-kb transcript and pre-
mRNA forms (Figure 5A, middle and lower panels).
The RT-PCR speciﬁc bands are not due to genomic con-
tamination, since RT-PCR without RT did not yield any
bands.
Moreover, real-time quantitative RT-PCR experiments
were performed in order to further verify the HuR-bound
mRNA levels in relation to a housekeeping mRNA,
RPL0, as background control. There were extremely low
background levels of RPL0 mRNA levels bound to both
IgG and anti-HuR (Figure 5B). However, signiﬁcant
HuR-bound HuR mRNA levels were seen in comparison
to IgG control.
To further conﬁrm that HuR can bind to the HuR
ARE region, gel mobility shift assay was performed
using biotinylated HuR ARE RNA probes. Two promi-
nent ARE–protein complexes could be seen to interact
with the HuR ARE but not with unlabeled competitor
(Figure 5C, lanes 2 and 3, respectively). A band is shifted
with an anti-HuR monoclonal antibody (Figure 5C, lane
4). To verify the direct binding of HuR to the HuR ARE,
in vitro translated HuR was found to bind to the HuR
ARE but not the mutant ARE (Figure 5C, lanes 5 and
6, respectively).
Functional TTP competition with HuR auto-regulation
Since it is known that RNA-binding proteins that promote
mRNA decay can compete for HuR, we over-expressed
TTP and the zinc ﬁnger mutant (C124R) and subsequently
measure the HuR mRNA levels bound to HuR using the
IP-RNA approach-with normalization of RNA levels
using housekeeping/background control (RPL0). TTP
but not the mutant TTP competed for HuR binding to
HuR mRNA (Figure 6A). When normalized to RPL0
mRNA levels, there was a 28-fold increase in HuR binding
to HuR mRNA in vector-transfected cells, whereas wild-
type TTP reduced the HuR binding by  2-fold. The zinc
ﬁnger TTP mutant has been suggested as dominant-
negative (32) and indeed increased the binding of HuR
to HuR mRNA by 2-fold (Figure 6A). This is also
reﬂected in the reporter assays; the mutant TTP increased,
nearly by 2-fold (P<0.01), the activity from the reporter
expressed from the construct with the ARE-bearing 6-kb
HuR mRNA 30UTR when compared to the vector control
(pCR3.1). Whereas the wild-type TTP decreased the
reporter activity from the construct with 6-kb HuR
mRNA 30UTR (Figure 6B), there was no eﬀect of the
wild-type or mutant TTP on the reporter activity
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Figure 6. Functional TTP-mediated antagonism of HuR autoregula-
tion. (A) HEK293 cells were transfected with pCR3.1 vector, wild-
type TTP vector or the zinc ﬁnger C124R mutant for overnight. Cell
lysates were obtained, and RNA materials obtained by precipitation
with either anti-HuR antibody or goat IgG control antibody were
used for real-time quantitative PCR. The real-time RT-PCR was per-
formed with primers/TaqMan probe speciﬁc to HuR mRNA and RPL0
(background control). Data show RPL0-normalized anti-HuR/PRL0-
normalized anti-IgG ratios. Data are from one representative experi-
ment (mean SEM of triplicate) of two.    Denotes P-values of <0.005
one-way ANOVA test for the three group comparisons. (B) HEK293
cells in 96-well plates were co-transfected with 30-ng pCR3.1 empty
vector, TTP or C124R TTP and 25ng of each of EGFP-30UTR repor-
ter vectors as indicated. The reporter 30UTR constructs are described in
Figure 3A. The ﬂuorescence levels obtained from cells transfected with
the pCR3.1 and the reporter construct with control 30UTR were
taken as 100%. The y-axis numbers represent percentages of this con-
trol.    Denotes P-values of <0.001 two-way ANOVA test when com-
pared to the control group. (C) HEK293 cells in 96-well plates were
co-transfected with 30-ng pCR3.1 empty vector, TTP or C124R TTP
and 25ng of each of EGFP-30UTR reporter vectors as indicated. The
reporter vector is EGFP fused with 30UTR that contains a 60nt corre-
sponding to the ARE regions from HuR 6-kb variant 30UTR, uPA
30UTR, their mutant forms, and control GH1 sequence (Figure 3D,
inset table). Fluorescence data of mean SEM of quadruplicates were
obtained. The ﬂuorescence levels obtained from cells transfected with
the pCR3.1 and the reporter with control 30UTR were taken as 100%.
The y-axis numbers represent percentages of this control.   Denotes
P-values of <0.01 two-way ANOVA test when compared to the control
group.
Nucleic Acids Research, 2009,Vol.37, No. 11 3621generated from the construct with the 2.7-kb HuR 30UTR
or the control EEF1A1 30UTR (Figure 6B).
Further, we used the minimal 60-nt regions of the HuR
ARE and uPA ARE (as a positive control), and GH1
(non-ARE control sequence) to study the eﬀects of wild-
type TTP and mutant TTP. The eﬀect of mutant TTP
( 1.6-fold, P<0.01) was seen with the HuR ARE and
uPA ARE but not with the mutant sequences or GH1
control (Figure 6C). The eﬀect of wild-type TTP was min-
imal in contrast to the larger 30UTRs. However, there was
signiﬁcant statistical diﬀerence in the case of HuR ARE
and uPA ARE column groups in contrast to other column
groups when the two-away ANOVA test was used
(Figure 6C).
DISCUSSION
We show that HuR mRNA has long 30untranslated
region with multiple polyadenylation sites that results in
alternative variants with diﬀerential ARE involvement
and diﬀerential stability. Moreover, the diﬀerent alterna-
tive variants have diﬀerential response to HuR-induced
stabilization and TTP-induced destabilization. The long
ARE-bearing transcript of HuR is labile and it constitutes
the rare alternative form of HuR mRNA species. The low
abundance of HuR can be explained by its lability to
RNA destabilizing proteins, such as TTP. The HuR
mRNA, particularly the ARE-bearing transcript binds
and responds to HuR protein itself, thus, an auto-regula-
tory role of HuR is revealed in this paper.
The ﬁnding of alternative polyadenylation variants,
such as the ones in this study, is facilitated by bioinfor-
matics, speciﬁcally, alignment and clustering/assembly of
cDNA and EST sequences (19,33,34). We used the
Unigene record of ELAVL1 gene (HuR), which contains
both the cDNA and EST sequences. The EST records
(35), which are now in millions of records, are a rich
source for the 30end ESTs that constitute the 30UTR har-
boring putative alternative polyadenylation variants.
Alternative polyadenylation occurs mostly as a result of
usage of multiple poly(A) sites in the 30UTR. It appears
that this is widespread and can aﬀect tissue-speciﬁc expres-
sion, mRNA localization, mRNA decay and translation
eﬃciency (36–40). Additionally, alternative polyadenyla-
tion may have a role in certain disease situations (20).
Alternative polyadenylation that leads to ARE-
containing and non-ARE-containing transcripts can
cause diﬀerential expression patterns. A notable example
is COX-2 mRNA, which has been shown to have both
ARE-deﬁcient and ARE-proﬁcient transcripts that diﬀer
in their abundance of expression in cancer due to alterna-
tive polyadenylation (41,42) and that TTP binds only the
most distal AREs and promotes the decay of the longer
isoform (42). In our study, we have shown that the distal
ARE can destabilize the HuR 6-kb alternative polyadeny-
lation variant, while the proximal region does not aﬀect
the 2.7-kb HuR mRNA that lacks the typical ARE, lead-
ing to their diﬀerential abundance. In addition, the distal
ARE-containing 6-kb variant binds HuR protein itself
and it is responsive to HuR-mediated upregulation of
the activity of the reporter fused with the 6-kb 30UTR
sequence. Additionally, these observations were conﬁrmed
with a minimal region of ARE in the HuR 6-kb transcript.
RNA-immunoprecipitation experiments indicated that the
6-kb transcripts are bound to HuR and also to intron
containing sequence (pre-mRNA). In general, this is
the case with many RNA-binding proteins, which pre-
dominantly associate with the pre-mRNAs of their targets
(9,11).
The activities of the RNA-stabilizing activity of HuR
and the RNA decay-promoting proteins, such as TTP,
KSRP and AUF1, can compete for both the binding
and the activity on the target mRNA. In normal cells or
in the absence of external stimulus, ARE-mRNAs tend to
be of low abundance due to the activity of RNA destabi-
lizing proteins. In tumor cells or during cell cycle, also
in response to stimuli, HuR may stabilize mRNA by the
displacement or inhibition of factors that speciﬁcally
cleave or deadenylate these mRNAs, such as TTP,
KSRP or AUF1 (43,44). In our results, and in the absence
of HuR ectopic expression, the long HuR polyadenylation
mRNA variant is kept low because of the action of RNA
destabilizing proteins, such as TTP, since over-expression
of TTP reduced HuR binding to its HuR mRNA. In con-
trast, the mutant zinc ﬁnger TTP, which acts a dominant
negative (32), increased the binding of HuR to HuR
mRNA and HuR activity. The mutant TTP used here
has a single-point mutation (Cys to Arg) in ﬁrst of the
two zinc ﬁnger domains of TTP, which leads to non-
binding to the AREs (32,45). The dominant negative
eﬀect of the mutant TTP is likely due to the non-binding
to the ARE and thus lack of TTP decay-promoting action,
leading to further permission of HuR action. Another
explanation is that mutant TTP inhibits the activity of
other proteins involved in the degradation of the mRNA
(45). During HuR over-expression, HuR can displace
TTP, AUF1 or others, leading to stabilization of HuR
mRNA. It has been shown that HuR over-expression
led to displacement of AUF1 from c-fos AREs (46). It
has been also shown that siRNA-mediated knockdown
of HuR led to larger AUF1 association with cyclin D
and p21 mRNAs (11). Ectopic expression of HuR over-
comes TTP-mediated destabilization of IL-3 mRNA in
ARE-dependent manner (47). Ectopic expression of TTP
was also found to be competing for HuR binding toward
IL-8 and VEGF mRNA. These results support our ﬁnd-
ings that TTP and HuR are competing with each other for
HuR mRNA.
Both the expression and cytoplasmic localization of
HuR protein has been linked in many types of cancer
including colon, breast and others (21–25,48–52).
Because of the involvement of HuR in human pathology,
particularly, in cancer, further understanding of post-tran-
scriptional regulation of HuR gene is needed. Alternative
polyadenylation is an important gene-expression-tuning
mechanism. It is estimated that half of mammalian
genes encode alternative polyadenylation variants (33).
Many of these genes have multiple poly(A) sites
that may be diﬀerentially used during development, pro-
liferation and diﬀerentiation, and can be tissue-speciﬁc
regulated (37,38,40). These alternative polyadenylation
3622 Nucleic Acids Research, 2009, Vol. 37,No. 11variants have 30 untranslated regions (30UTR) with vari-
ous lengths and may harbor diﬀerential sequence regula-
tory elements such as the ARE. The existence of
two transcripts generated by the use of alternative poly-
adenylation sequences that diﬀer in their 30UTRs and
the diﬀerential presence of AREs have been documented
in a number of genes. Notably, these are cyclooxygenase 2
(COX-2), cyclin D1, vascular endothelial factor, ﬁbroblast
growth factor 2 and rat receptor for advanced glycation
end products (41,53–57).
In this study, we used bioinformatics and experimental
approaches to ﬁnd and assess the functional role of HuR
polyadenylation variants in mRNA abundance, ARE
involvement and response to HuR and TTP. The auto-
regulatory role of HuR may amplify the pathological
role of HuR, particularly, in cancer; and small molecule
drugs that disturb the binding of HuR to HuR 30UTR can
be used as therapeutics
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